[Treatment of esophageal cancer by endoscopic administration of peplomycin ointment].
Pepleomycin ointment was developed to improve the antitumor activity afforded by endoscopic therapy for esophageal cancer. Through the esophagoscope we could observe this ointment specifically attacking the lesion. Furthermore we were able to recognize that peplomycin was acting directly on the lymph nodes as well as the tumor in a resected portion of the esophagus. It is hopefully anticipated that this method will be used as a combination therapy in pre-operative and inoperable esophageal cancer.
D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage*; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D004945:Esophagoscopy / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments; D017663:Peplomycin
D000903:Antibiotics, Antineoplastic; D009824:Ointments; D001761:Bleomycin; D017663:Peplomycin